<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[AngioDynamics Inc. | Company News & Executive Profiles - ANGO | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/angiodynamics+inc..html?i=8]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for AngioDynamics Inc.]]></description>
	<s:counts start="0" returned="10" found="17" />
	<language>en-us</language>
	<item>
		<title><![CDATA[AngioDynamics F1Q10 (Qtr End 9/30/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14046_23-349947.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions Our first question comes from the line of Christopher Warren with Caris & Company.  Christopher Warren - Caris & Co. Thanks so much and it&#8217;s very gratifying to see you guys above the consensus for the quarter. My question is to what extent...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 06 Oct 2009 15:55:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/caris+%2526+co..html"><![CDATA[Caris & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales+tools.html"><![CDATA[Sales Tools]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/angiodynamics+inc..html"><![CDATA[AngioDynamics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANGO</category>
		<category domain="tickers">ANGO</category>
	</item>
	<item>
		<title><![CDATA[AngioDynamics, Inc. F4Q09 (Qtr End 03/31/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14046_23-321748.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions. Our first question is from the line of Jason Mills - Canaccord Adams. Jason Mills - Canaccord Adams First question is more of a macro question with respect to your markets.  Perhaps it would be helpful if you could give your assessment of...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 16 Jul 2009 20:43:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/growth.html"><![CDATA[Growth]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/angiodynamics+inc..html"><![CDATA[AngioDynamics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANGO</category>
		<category domain="tickers">ANGO</category>
	</item>
	<item>
		<title><![CDATA[AngioDynamics, Inc. F4Q09 (Qtr End 03/31/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F149365-angiodynamics-inc-f4q09-qtr-end-03-31-09-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[AngioDynamics Inc. ANGO   F4Q09 Earnings Call   July 16, 2009 4:30 pm ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 16 Jul 2009 09:43:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/angiodynamics+inc..html"><![CDATA[AngioDynamics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANGO</category>
		<category domain="tickers">ANGO</category>
	</item>
	<item>
		<title><![CDATA[AngioDynamics Inc., F3Q09 (Qtr End 02/28/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14046_23-284839.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Operator Instructions.  Our first question is from the line of Gregory Brash - Sidoti & Company. Gregory Brash - Sidoti & Company Hi Jan, welcome aboard.  Just want to start off and I know you&#8217;re not giving guidance out here for 2010, but...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 02 Apr 2009 18:21:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/guidance.html"><![CDATA[Guidance]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/angiodynamics+inc..html"><![CDATA[AngioDynamics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/supply+chain+management+%2528scm%2529.html"><![CDATA[Supply Chain Management (SCM)]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANGO</category>
		<category domain="tickers">ANGO</category>
	</item>
	<item>
		<title><![CDATA[AngioDynamics' Less Than Stellar Quarter]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F113961-angiodynamics-less-than-stellar-quarter%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Douglas Cress submits: It&#8217;s been a roller coaster of a year for AngioDynamics ANGO. In the past, I&#8217;ve professed my high opinion of the company. I still like ANGO and I think it&#8217;s fairly valued, but a less than stellar quarter should give growth-obsessed investors pause. The company expects revenues...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 09 Jan 2009 12:35:27 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/douglas+cress.html"><![CDATA[Douglas Cress]]></category>
		<category domain="http://resources.bnet.com/topic/angiodynamics+inc..html"><![CDATA[AngioDynamics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANGO</category>
		<category domain="tickers">ANGO</category>
	</item>
	<item>
		<title><![CDATA[AngioDynamics Inc., F2Q09 (Qtr End 11/30/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14046_23-257847.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions.  Our first question is from the line of Jason Mills with Canaccord Adams. Jason Mills - Canaccord Adams Eamonn, first I have two questions and then will get back in queue; I wanted to ask you about the leadership transition and specifically your transition...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 06 Jan 2009 19:35:35 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/relationship.html"><![CDATA[Relationship]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/ceo.html"><![CDATA[CEO]]></category>
		<category domain="http://resources.bnet.com/topic/angiodynamics+inc..html"><![CDATA[AngioDynamics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/leadership.html"><![CDATA[Leadership]]></category>
		<category domain="http://resources.bnet.com/topic/product+development.html"><![CDATA[Product Development]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANGO</category>
		<category domain="tickers">ANGO</category>
	</item>
	<item>
		<title><![CDATA[AngioDynamics: Good Time to Buy]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F109334-angiodynamics-good-time-to-buy%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Douglas Cress submits: Changes are afoot at Queensbury NY-based AngionDynamics ANGO. The company said on Wednesday that it would begin the search for a new CEO to replace company co-founder Eamonn Hobbs. Hobbs will continue on as Vice Chairman of the Board of Directors where he will focus on the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 05 Dec 2008 12:16:10 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/douglas+cress.html"><![CDATA[Douglas Cress]]></category>
		<category domain="http://resources.bnet.com/topic/angiodynamics+inc..html"><![CDATA[AngioDynamics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANGO</category>
		<category domain="tickers">ANGO</category>
	</item>
	<item>
		<title><![CDATA[AngioDynamics F1Q09 (Qtr End 8/31/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14046_23-238894.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions Our first question comes from the line of Phil Nalbone from RBC.  Phillip E. Nalbone - RBC Capital Markets Good afternoon. Since I was just about to be told by Doug Sherk for a second time to ask only two questions, let me...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 02 Oct 2008 18:32:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/angiodynamics+inc..html"><![CDATA[AngioDynamics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANGO</category>
		<category domain="tickers">ANGO</category>
	</item>
	<item>
		<title><![CDATA[Medical Devices Are Solid Long-Term]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F90695-medical-devices-are-solid-long-term%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   One sector that has kept a promising longer-term outlook is medical devices and supplies. We recently met with Zacks senior analyst Christopher Titus, CFA regarding his outlook on the group, and which companies he would recommend.  How has earnings season gone so far?  Any...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 13 Aug 2008 02:04:13 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/angiodynamics+inc..html"><![CDATA[AngioDynamics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/arthrocare+corp..html"><![CDATA[ArthroCare Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/c.+r.+bard+inc..html"><![CDATA[C. R. Bard Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/becton%252c+dickinson+and+co..html"><![CDATA[Becton, Dickinson and Co.]]></category>
		<category domain="http://resources.bnet.com/topic/boston+scientific+corp..html"><![CDATA[Boston Scientific Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/hanger+orthopedic+group+inc..html"><![CDATA[Hanger Orthopedic Group Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANGO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ARTC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BSX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BCR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HGR</category>
		<category domain="tickers">ANGO,ARTC,BSX,BCR,HGR</category>
	</item>
	<item>
		<title><![CDATA[AngioDynamics Inc. F4Q08 (Qtr End 5/31/08) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14046_23-225289.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you, sir. Operator Instructions. Our first question comes from the line of Phil Nalbone with RBC Capital Markets. Please go ahead, sir. Phil Nalbone - RBC Capital Markets Hi, guys. Congratulations on such a strong finish to a very turbulent fiscal year. Eamonn Hobbs Thank you...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 28 Jul 2008 10:35:21 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/angiodynamics+inc..html"><![CDATA[AngioDynamics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ANGO</category>
		<category domain="tickers">ANGO</category>
	</item>
</channel>
</rss>
